Cargando…

Antibody response to SARS-CoV-2 in people living with HIV

Detalles Bibliográficos
Autores principales:	Yamamoto, Shinya, Saito, Makoto, Nagai, Etsuko, Toriuchi, Keiko, Nagai, Hiroyuki, Yotsuyanagi, Hiroshi, Nakagama, Yu, Kido, Yasutoshi, Adachi, Eisuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531336/ https://www.ncbi.nlm.nih.gov/pubmed/33046418 http://dx.doi.org/10.1016/j.jmii.2020.09.005

Ejemplares similares

Anti-spike protein antibody titer at the time of breakthrough infection of SARS-CoV-2 omicron
por: Adachi, Eisuke, et al.
Publicado: (2022)

Infiltrative Shadows in COVID-19: Pneumonia or Pulmonary Embolism?
por: Nagai, Hiroyuki, et al.
Publicado: (2020)

Gargle Lavage as a Safe and Sensitive Alternative to Swab Samples to Diagnose COVID-19: A Case Report in Japan
por: Saito, Makoto, et al.
Publicado: (2020)

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
por: Takashita, Emi, et al.
Publicado: (2022)

Favorable Outcome Following Sotrovimab Monoclonal Antibody in a Patient with Prolonged SARS-CoV-2 Omicron Infection with HIV/AIDS
por: Adachi, Eisuke, et al.
Publicado: (2022)

Mpox associated with Panton-Valentin leucocidin-producing methicillin-resistant Staphylococcus aureus among people with HIV
por: Adachi, Eisuke, et al.
Publicado: (2023)

Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan
por: Ikeuchi, Kazuhiko, et al.
Publicado: (2020)

Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB
por: Uraki, Ryuta, et al.
Publicado: (2023)

Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate
por: Uraki, Ryuta, et al.
Publicado: (2023)

Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1
por: Uraki, Ryuta, et al.
Publicado: (2023)

Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate
por: Uraki, Ryuta, et al.
Publicado: (2023)

Prevalence of HIV infection among non-elderly individuals with hepatitis C in Japan: a population-based cohort study using a health insurance claim data
por: Ikeuchi, Kazuhiko, et al.
Publicado: (2022)

Antibody Avidity Maturation Following Recovery From Infection or the Booster Vaccination Grants Breadth of SARS-CoV-2 Neutralizing Capacity
por: Nakagama, Yu, et al.
Publicado: (2022)

A Dual-Antigen SARS-CoV-2 Serological Assay Reflects Antibody Avidity
por: Nakagama, Yu, et al.
Publicado: (2022)

Gastric Syphilis in a Human Immunodeficiency Virus–Infected Patient
por: Adachi, Eisuke, et al.
Publicado: (2019)

Immunostaining of Cryptosporidiosis with Human Immunodeficiency Virus Infection
por: Adachi, Eisuke, et al.
Publicado: (2016)

Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination
por: Yamamoto, Shinya, et al.
Publicado: (2023)

Imported Tungiasis in a Non-endemic Country
por: Adachi, Eisuke, et al.
Publicado: (2018)

The human microbiome and COVID-19: A systematic review
por: Yamamoto, Shinya, et al.
Publicado: (2021)

Drug resistance mutations among people living with HIV with treatment failure in Henan Province, China
por: Liu, Jinjin, et al.
Publicado: (2023)

In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
por: Takashita, Emi, et al.
Publicado: (2022)

Prevalence of SARS-CoV-2–Specific Antibodies, Japan, June 2020
por: Yoshiyama, Takashi, et al.
Publicado: (2021)

Inflammatory cardiomyopathy of possibly overlapping aetiology: a case posing treatment dilemma and potential association
por: Nakagama, Shun, et al.
Publicado: (2021)

Development of a nursing intervention to facilitate optimal antiretroviral-treatment taking among people living with HIV
por: Ramirez-Garcia, Pilar, et al.
Publicado: (2009)

Antiretroviral therapy-naïve people living with HIV tend to have more severe symptoms of COVID-19
por: Sun, Jinfeng, et al.
Publicado: (2023)

Antibody titers against SARS-CoV-2 decline, but do not disappear for several months
por: Yamayoshi, Seiya, et al.
Publicado: (2021)

Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study
por: Nakashima, Kei, et al.
Publicado: (2022)

Patients with B-cell malignancies experience reduced antibody responses with class switching defect following BNT162b2 SARS-CoV-2 vaccination
por: Nakagama, Yu, et al.
Publicado: (2023)

A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1
por: Yu, Haisheng, et al.
Publicado: (2023)

Adherence level to antiretroviral therapy predict the time to viral load suppression of adult people living with HIV on antiretroviral therapy in Arba Minch general hospital
por: Hussen, Sultan, et al.
Publicado: (2019)

Trials of Tuberculosis-Preventive Therapy in People with HIV Infection
por: Swindells, Susan, et al.
Publicado: (2020)

Serological Testing Reveals the Hidden COVID-19 Burden among Health Care Workers Experiencing a SARS-CoV-2 Nosocomial Outbreak
por: Nakagama, Yu, et al.
Publicado: (2021)

Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
por: Nishikubo, Masashi, et al.
Publicado: (2023)

Estrogenicity of Styrene Oligomers: Response to Ohno et al.
por: Ohyama, Ken-ichi, et al.
Publicado: (2002)

Low raltegravir transfer into the breastmilk of a woman living with HIV
por: Feiterna-Sperling, Cornelia, et al.
Publicado: (2020)

Age-adjusted impact of prior COVID-19 on SARS-CoV-2 mRNA vaccine response
por: Nakagama, Sachie, et al.
Publicado: (2023)

Disseminated Tuberculosis with Cholecystitis in a Patient after Cord Blood Transplantation
por: Konuma, Takaaki, et al.
Publicado: (2020)

Detecting Waning Serological Response with Commercial Immunoassays: 18-Month Longitudinal Follow-up of Anti-SARS-CoV-2 Nucleocapsid Antibodies
por: Nakagama, Yu, et al.
Publicado: (2022)

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
por: Sciascia, Savino, et al.
Publicado: (2021)

Psychosocial impact of COVID-19 pandemic lockdown on people living with eye diseases in the UK
por: Ting, Darren Shu Jeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_52m3hmpc4v354gvr0gt637ns32